Antipsychotic treatment for late-life schizophrenia.

Abstract

The clinical characteristics of schizophrenia in older persons vary to some extent, depending on whether the onset of illness was earlier or later in life. Regardless of age of onset, antipsychotic medications are the mainstay of treatment. Age-related physiologic changes make older persons more sensitive to the therapeutic and toxic effects of antipsychotics. There is a paucity of controlled studies on the efficacy of antipsychotic medications in older persons with schizophrenia. Existing data suggest that atypical antipsychotics are at least as efficacious as and better tolerated than the conventional agents. In late-life schizophrenia, important adverse effects of antipsychotics include sedating, anticholinergic and cardiovascular effects, extrapyramidal symptoms, and tardive dyskinesia. Certain atypical antipsychotics are associated with a risk of metabolic changes as well as agranulocytosis. Clinical recommendations include a thorough diagnostic evaluation followed by treatment with low doses of atypical antipsychotics. Medication alone is likely to be less effective than when it is combined with an appropriate psychosocial intervention.

• Authors: Jeremy A Sable, Dilip V Jeste
• Journal: Current psychiatry reports (Curr Psychiatry Rep) Vol. 4 Issue 4 Pg. 299-306 (Aug 2002) ISSN: 1523-3812 [Print] United States
• PMID: 12126599 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review)

Chemical References

• Antipsychotic Agents

Topics

• Age Factors
• Aged
• Antipsychotic Agents (adverse effects, therapeutic use)
• Health Status
• Humans
• Middle Aged
• Schizophrenia (drug therapy)